Amy J Morgan, PA
Physician Assistant · Seattle
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 26 years
- Graduated 2000
Offices
3 locations · The Association of University Physicians · 3,484 clinicians in this group
Hospitals listed: Fred Hutchinson Cancer Center · University of Washington Medical Ctr. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Amy J Morgan’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Washington PA.PA.60225029Physician Assistant License · since 2011 · expires 2028-05-11ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- University of Washington Medical CtrSeattle, WAAcute Care Hospital · Government - State · No emergency department · Birthing-friendlyPart of UW Medicine, which runs 4 hospitalsHome of Fred Hutchinson / University of Washington / Seattle Children's Cancer Consortium, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Postoperative respiratory failure rate: 4.94 (1.58 to 8.3) · 2,791 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 2.48 (0.42 to 4.54) · 3,047 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.42, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.1 (6 to 10.6) · 540 cases, Jan 2024 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,118 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for University of Washington Medical Ctr
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 3 better, 7 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative respiratory failure rateComplications and deaths | 4.94 (1.58 to 8.3) · 2,791 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.48 (0.42 to 4.54) · 3,047 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.42 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.1 (6 to 10.6) · 540 cases | Better | Jan 2024 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,118 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.41 to 1.87) · 3,356 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.68 to 1.06) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.77 (137.68 to 205.86) · 295 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.6 · 169 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 643 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 522 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 256 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 5,179 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.14 to 0.48) · 12,916 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.14 to 0.48) · 13,941 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (2.43 to 5.19) · 5,095 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.99 (0 to 2.05) · 3,007 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.24 (2.26 to 4.23) · 4,648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.45 to 3.02) · 1,296 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.85 (0.42 to 1.28) · 11,531 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 136 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.227 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.165 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.919 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.72 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.262 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 887 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -17.4 · 213 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -32.1 · 730 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 12 · 543 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 649 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.6 to 6.8) · 540 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 138 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 34 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 173 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.1 to 16.3) · 2,084 cases | No different | Jan 2022 – Dec 2024 |
What patients said (4,925 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$11,587
Medicare paid this office $11,587 for 58 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 38 | $6,877 | $100 |
| Return visit (30+ min) | 27 | $2,838 | $69 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 36 | $802 | $12 |
| Short return visit (20+ min) | 11 | $565 | $43 |
Procedures year by year
| Procedure | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 11 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
58 Original Medicare patients in 2024. Average age 71 · Women 62% · Health risk score 2.44. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 60% · Cancer 36% · Diabetes 24% · Depression 22% · Coronary heart disease 19% · Heart failure 19%.
The office billed $51,089, Medicare allowed $14,908 and paid $11,587; for 198 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 58 | 198 | 71 | 2.44 | $51,089 | $11,587 |
| 2023 | 47 | 142 | 71 | 2.21 | $44,891 | $11,970 |
| 2022 | 61 | 130 | 71 | 2.21 | $36,467 | $11,443 |
| 2021 | 32 | 58 | 70 | 3.01 | $14,962 | $5,295 |
| 2019 | 40 | 44 | 72 | 1.34 | $14,885 | $2,015 |
| 2018 | 164 | 247 | 72 | 1.39 | $76,496 | $17,249 |
| 2017 | 50 | 94 | 70 | 2.28 | $19,006 | $4,797 |
| 2016 | 61 | 78 | 71 | 1.41 | $16,431 | $5,018 |
| 2015 | 63 | 89 | 72 | 1.34 | $17,430 | $5,912 |
| 2014 | 42 | 69 | 72 | 1.50 | $11,166 | $3,455 |
| 2013 | 103 | 197 | 67 | 1.18 | $22,794 | $7,734 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Long return visit (40+ min) | 36 | $8,644 | $98 |
| Return visit (30+ min) | 24 | $2,659 | $65 |
2022: 2 services
| Long return visit (40+ min) | 44 | $8,396 | $97 |
| Return visit (30+ min) | 20 | $2,386 | $72 |
2021: 2 services
| Long return visit (40+ min) | 21 | $3,277 | $109 |
| Return visit (30+ min) | 15 | $1,706 | $74 |
2019: 1 service
| Return visit (30+ min) | 27 | $850 | $29 |
2018: 3 services
| Return visit (30+ min) | 75 | $7,691 | $73 |
| Short return visit (20+ min) | 78 | $4,112 | $48 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 11 | $1,087 | $99 |
2017: 3 services
| Return visit (30+ min) | 14 | $1,799 | $60 |
| Return visit (30+ min) | 14 | $1,319 | $60 |
| Short return visit (20+ min) | 20 | $869 | $36 |
2016: 2 services
| Return visit (30+ min) | 46 | $3,519 | $65 |
| Short return visit (20+ min) | 12 | $613 | $51 |
2015: 1 service
| Return visit (30+ min) | 50 | $4,226 | $74 |
2014: 2 services
| Return visit (30+ min) | 21 | $2,070 | $67 |
| Short return visit (20+ min) | 12 | $572 | $44 |
2013: 4 services
| Return visit (30+ min) | 56 | $4,407 | $75 |
| Short return visit (20+ min) | 17 | $997 | $52 |
| Hemoglobin a1c level | 13 | $198 | $13 |
| Blood glucose (sugar) test performed by hand-held instrument | 20 | $79 | $2 |
Drugs they prescribed that Part D paid
$334,816
Pharmacies billed $334,816 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 20% of their Part D prescriptions (56 of 275) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%. Long-acting opioids: 39% of their opioid prescriptions.
237 generic and 38 brand-name prescriptions · $334,816 in drug cost · 15 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Imatinib Mesylate | 30 | $16,032 | $534 |
| Fentanyl | 14 | $1,991 | $142 |
| Gabapentin | 20 | $238 | $12 |
| Oxycodone | 18 | $176 | $10 |
| Pantoprazole | 12 | $71 | $6 |
Year by year
| 2024 | 275 | 58 | 20% (56) | 14% | $334,816 |
| 2023 | 434 | 71 | 9% (41) | None | $148,495 |
| 2022 | 337 | 65 | 13% (43) | None | $154,397 |
| 2021 | 123 | 35 | 20% (25) | 14% | $130,166 |
| 2020 | 26 | 15 | None | None | $1,571 |
| 2019 | 125 | 48 | 14% (17) | None | $11,590 |
| 2018 | 263 | 95 | 14% (36) | 14% | $19,355 |
| 2017 | 237 | 77 | 14% (33) | 19% | $147,404 |
| 2016 | 238 | 77 | 9% (22) | 25% | $25,915 |
| 2015 | 317 | 87 | 7% (23) | None | $23,052 |
| 2014 | 437 | 111 | 9% (39) | None | $37,459 |
| 2013 | 858 | 162 | 8% (65) | None | $36,640 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Eliquis | 19 | $12,671 | $667 |
| Imatinib Mesylate | 20 | $5,100 | $255 |
| Potassium Chloride | 29 | $1,011 | $35 |
| Gabapentin | 21 | $435 | $21 |
| Pantoprazole | 25 | $264 | $11 |
| Prochlorperazine Maleate | 11 | $260 | $24 |
| Ondansetron | 12 | $219 | $18 |
| Oxycodone | 17 | $181 | $11 |
| Levothyroxine | 15 | $124 | $8 |
| Dexamethasone | 16 | $101 | $6 |
| Prednisone | 14 | $71 | $5 |
| Levofloxacin | 18 | $53 | $3 |
| Furosemide | 13 | $46 | $4 |
2022: 7 drugs
| Imatinib Mesylate | 29 | $39,153 | $1,350 |
| Eliquis | 27 | $17,887 | $662 |
| Fentanyl | 11 | $1,363 | $124 |
| Gabapentin | 23 | $331 | $14 |
| Prochlorperazine Maleate | 13 | $250 | $19 |
| Levothyroxine | 15 | $156 | $10 |
| Dexamethasone | 12 | $118 | $10 |
2021: 3 drugs
| Imatinib Mesylate | 12 | $6,766 | $564 |
| Oxycodone | 14 | $105 | $8 |
| Gabapentin | 11 | $67 | $6 |
2019: 3 drugs
| Estradiol | 17 | $4,372 | $257 |
| Lidocaine | 20 | $1,286 | $64 |
| Oxycodone | 13 | $117 | $9 |
2018: 5 drugs
| Estradiol | 12 | $2,608 | $217 |
| Ondansetron | 28 | $626 | $22 |
| Oxycodone | 21 | $130 | $6 |
| Prochlorperazine Maleate | 12 | $104 | $9 |
| Lorazepam | 16 | $73 | $5 |
2017: 5 drugs
| Zejula | 12 | $95,725 | $7,977 |
| Lorazepam | 24 | $227 | $9 |
| Zolpidem | 17 | $202 | $12 |
| Oxycodone | 18 | $164 | $9 |
| Ondansetron | 11 | $93 | $8 |
2016: 4 drugs
| Premarin | 23 | $9,016 | $392 |
| Megestrol Acetate | 12 | $603 | $50 |
| Triamcinolone Acetonide | 23 | $273 | $12 |
| Gabapentin | 14 | $135 | $10 |
2015: 9 drugs
| Premarin | 21 | $6,683 | $318 |
| Estrace | 12 | $2,657 | $221 |
| Ondansetron | 27 | $435 | $16 |
| Oxycodone | 16 | $257 | $16 |
| Polyethylene Glycol 3350 | 13 | $120 | $9 |
| Gabapentin | 13 | $109 | $8 |
| Prochlorperazine Maleate | 12 | $59 | $5 |
| Dexamethasone | 13 | $45 | $3 |
| Lorazepam | 11 | $42 | $4 |
2014: 12 drugs
| Neupogen | 12 | $13,783 | $1,149 |
| Vagifem | 17 | $4,055 | $239 |
| Premarin | 13 | $3,641 | $280 |
| Ondansetron | 44 | $689 | $16 |
| Prochlorperazine Maleate | 26 | $490 | $19 |
| Lidocaine-Prilocaine | 17 | $437 | $26 |
| Oxycodone | 11 | $179 | $16 |
| Hydrocodone-Acetaminophen | 11 | $158 | $14 |
| Gabapentin | 14 | $128 | $9 |
| Lorazepam | 19 | $117 | $6 |
| Ranitidine | 17 | $114 | $7 |
| Omeprazole | 15 | $79 | $5 |
2013: 25 drugs
| Spiriva | 14 | $3,839 | $274 |
| Gabapentin | 22 | $907 | $41 |
| Lovastatin | 47 | $896 | $19 |
| Tramadol | 21 | $759 | $36 |
| Proair Hfa | 16 | $756 | $47 |
| Metformin | 31 | $525 | $17 |
| Fluticasone Propionate | 20 | $438 | $22 |
| Omeprazole | 16 | $403 | $25 |
| Montelukast | 12 | $333 | $28 |
| Lisinopril | 24 | $315 | $13 |
| Amlodipine Besylate | 35 | $304 | $9 |
| Tamsulosin | 11 | $284 | $26 |
| Atenolol | 27 | $232 | $9 |
| Hydrochlorothiazide | 25 | $225 | $9 |
| Alendronate | 13 | $208 | $16 |
| Hydrocodone-Acetaminophen | 14 | $184 | $13 |
| Levothyroxine | 22 | $181 | $8 |
| Ondansetron | 13 | $173 | $13 |
| Losartan | 11 | $153 | $14 |
| Simvastatin | 20 | $151 | $8 |
| Prochlorperazine Maleate | 14 | $145 | $10 |
| Enalapril Maleate | 13 | $127 | $10 |
| Ranitidine | 17 | $120 | $7 |
| Furosemide | 25 | $118 | $5 |
| Lorazepam | 11 | $66 | $6 |
Money from drug and device companies
$118 in 2024
A payment is not proof that care is biased.
| SpringWorks Therapeutics | Ogsiveo | $118 | 1 payment
|
See the published payment
| SpringWorks Therapeutics | Meals · 2024-04-25 | Ogsiveo | $118 |
Professional record
- NPI
- 1649209131
- Licence
- WA PA60225029Washington PA.PA.60225029: Active
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- WA 1649209131
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 11511 Ne 10th St, Bellevue, WA, 98004
- NPI first listed
- 2006-06-30
- NPI last updated
- 2021-04-27
- NPI record certified
- 2021-04-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 825 Eastlake Ave E, Seattle, WA, 98109 · 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.